Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Overbaugh

Showing results (221-230 of 269) with videos related to

Pageof 27
Sort By:
Open Forum Infectious Diseases|January 23, 2018
Decay of HIV DNA in the Reservoir and the Impact of Short Treatment Interruption in Kenyan InfantsMark D Pankau, Dalton Wamalwa, Sarah Benki-Nugent, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan childrenDalton C Wamalwa, Carey Farquhar, Elizabeth M Obimbo, et al.
Genome Medicine|February 5, 2024
Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infectionAaron J Wilk, Joshua O Marceau, Samuel W Kazer, et al.
Plos Pathogens|February 20, 2019
Identification of HIV gp41-specific antibodies that mediate killing of infected cellsKatherine L Williams, Megan Stumpf, Nicole Elise Naiman, et al.
The Journal of Infectious Diseases|April 4, 2002
Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trialJared M Baeten, R Scott McClelland, Julie Overbaugh, et al.
Journal of Virology|June 16, 2005
Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infantsBarbara L Lohman, Jennifer A Slyker, Barbra A Richardson, et al.
AIDS (London, England)|August 2, 2008
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trialJudd L Walson, Phelgona A Otieno, Margaret Mbuchi, et al.
Cell Reports. Medicine|May 5, 2021
Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohortsZak A Yaffe, Nicole E Naiman, Jennifer Slyker, et al.
Mbio|February 25, 2026
Re-infection with SARS-CoV-2 is associated with increased antibody breadth and potency against diverse sarbecovirus strainsMichelle Lilly, Felicitas Ruiz, William B Foreman, et al.
AIDS (London, England)|May 14, 2016
Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancyDalton Wamalwa, Sarah Benki-Nugent, Agnes Langat, et al.
Pageof 27

Showing results (221-230 of 269) with videos related to

Sort By:
Pageof 27
Open Forum Infectious Diseases|January 23, 2018
Decay of HIV DNA in the Reservoir and the Impact of Short Treatment Interruption in Kenyan InfantsMark D Pankau, Dalton Wamalwa, Sarah Benki-Nugent, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan childrenDalton C Wamalwa, Carey Farquhar, Elizabeth M Obimbo, et al.
Genome Medicine|February 5, 2024
Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infectionAaron J Wilk, Joshua O Marceau, Samuel W Kazer, et al.
Plos Pathogens|February 20, 2019
Identification of HIV gp41-specific antibodies that mediate killing of infected cellsKatherine L Williams, Megan Stumpf, Nicole Elise Naiman, et al.
The Journal of Infectious Diseases|April 4, 2002
Vitamin A supplementation and human immunodeficiency virus type 1 shedding in women: results of a randomized clinical trialJared M Baeten, R Scott McClelland, Julie Overbaugh, et al.
Journal of Virology|June 16, 2005
Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infantsBarbara L Lohman, Jennifer A Slyker, Barbra A Richardson, et al.
AIDS (London, England)|August 2, 2008
Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trialJudd L Walson, Phelgona A Otieno, Margaret Mbuchi, et al.
Cell Reports. Medicine|May 5, 2021
Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohortsZak A Yaffe, Nicole E Naiman, Jennifer Slyker, et al.
Mbio|February 25, 2026
Re-infection with SARS-CoV-2 is associated with increased antibody breadth and potency against diverse sarbecovirus strainsMichelle Lilly, Felicitas Ruiz, William B Foreman, et al.
AIDS (London, England)|May 14, 2016
Treatment interruption after 2-year antiretroviral treatment initiated during acute/early HIV in infancyDalton Wamalwa, Sarah Benki-Nugent, Agnes Langat, et al.
Pageof 27